The company in question is, Merck & Co., Inc. (NYSE:MRK) currently with a stock price of 61.33 (-1.53% today). The market cap for Merck & Co., Inc. is 169862.64, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Merck & Co., Inc. is 65.47. Currently Merck & Co., Inc. is trading with a P/E of 33.59, and a forward P/E of 15.91. Average volume for Merck & Co., Inc. is 9899.4 and so far today it is 11244200.
Performance in the last year for Merck & Co., Inc. has been 21.57%. For EPS growth, Merck & Co., Inc. has seen a growth of -61.60%, and is looking to grow in the next year to 2.85%. More long term stats show that EPS growth has been 41.50% over the last five years and could be 6.27% for the next five years. Merck & Co., Inc. has seen sales growth quarter over quarter at 0.60%, with EPS growth quarter over quarter at 79.20%. The 20-day simple moving average is 0.75%, with the 200-day simple moving average coming to 12.11%.
Since the IPO date for Merck & Co., Inc. on the 1/2/1970, Merck & Co., Inc. has seen performance year to date to be 18.95%. With Merck & Co., Inc. trading at 61.33, the dividend yield is 3.00%, and the EPS is 1.83.
So could Merck & Co., Inc., be undervalued? Well as said before P/E is 33.59. The PEG is 5.35, P/S is 4.31 and the P/B is at 3.92. The P/cash is 14.35, with P/free cash flow at 35.78.
Merck & Co., Inc. ability to deal with debt shows that the current ratio is 1.9, and the quick ratio is 1.5. This is with long term debt/equity at 0.55, and total debt/equity at 0.56.
In terms of margins, Merck & Co., Inc. has a gross margin of 63.20%, an operating margin of 18.10% and a profit margin of 13.00%.Payout ratio for Merck & Co., Inc. is 99.50%. Return on assets come to 5.20% with return on investment coming to 6.40%.
Insider ownership for Merck & Co., Inc., is at 0.04% and institutional ownership comes to 75.00%. Outstanding shares are at 2769.65. While shares float is 2764.14. The float short is currently 1.09%, and short ratio is 3.03.